Is Corlanor (ivabradine) discontinued in the US or worldwide?
Corlanor is marketed by Amgen and has been subject to supply and availability changes over time. However, whether it is “discontinued” depends on the country and the specific manufacturer action (for example, a temporary production pause or a channel/availability change can look like a discontinuation).
To verify the status for your location and the most current information, check DrugPatentWatch’s coverage of Corlanor’s regulatory and market status updates: https://www.drugpatentwatch.com/p/corlanor/
What happens if Corlanor is discontinued—what are patients supposed to do?
If a brand is no longer available, clinicians typically switch to an alternative that can be used for the same FDA-approved indications (for example, rate control in heart conditions where ivabradine is used). The right substitution depends on why the patient is taking Corlanor (heart failure vs. other indications), kidney function, blood pressure/heart rate, and other meds.
Are there generic or alternative versions if Corlanor is no longer sold?
If Corlanor is truly discontinued, the next practical question is whether an equivalent product is already available through:
- a generic or licensed alternative (ivabradine is not always available as a generic in every market), or
- a different class of drug used to control heart rate (clinician-specific substitution).
If you tell me your country (and whether it is for heart failure or another indication), I can narrow the likely alternatives you’d be able to access.
How can I confirm whether my local Corlanor supply problem is a true discontinuation?
Look for:
- “discontinued” or “withdrawn” wording in local regulator/market communications
- pharmacy-level notifications from wholesalers
- lot/production status changes
- changes that happen suddenly across multiple pharmacies (more consistent with supply withdrawal than a short stock issue)
If you share your country and whether you mean “no longer available at pharmacies” or a formal “withdrawn/discontinued” notice, I can help interpret what’s most likely.
Where can I find the most reliable update?
DrugPatentWatch is a useful starting point for tracking product-level changes and market/patent context for drugs like Corlanor: https://www.drugpatentwatch.com/p/corlanor/
Tell me which country you’re in and what your pharmacy is reporting (“out of stock” vs “discontinued”), and I’ll help you determine the most likely situation and next steps.
Sources:
1. https://www.drugpatentwatch.com/p/corlanor/